Currently in the Indian pharmaceutical industry there are 24,000 companies competing for a market worth USD 5 billion.DUBLIN Dublin, city, Republic of Ireland
Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River. , Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles. -- Research and Markets (http://www.researchandmarkets.com/reports/c29907 ) has announced the addition of The Indian Pharmaceutical Industry to their offering
The Indian pharmaceutical industry grew at a very slow pace from 1947 to 1970, largely due to the lack of incentives and the failure of the government to set-up a concrete regulatory framework.
The environment under which the Indian pharmaceutical industry is operating is changing very slowly at present, but is likely to change significantly - and significantly faster - in the future.
Today, the industry is characterized char·ac·ter·ize
tr.v. character·ized, character·iz·ing, character·iz·es
1. To describe the qualities or peculiarities of: characterized the warden as ruthless.
2. by numerous governmental regulations and policy changes, stifling price controls, rigorous controls on formulations, and an absence of international patent protection. During 1970, the Indian Patents Act (IPA IPA - International Phonetic Alphabet ) and the Drug Price Control Order (Dpco) were passed. Although the Dpco acted as a buffer buffer, solution that can keep its relative acidity or alkalinity constant, i.e., keep its pH constant, despite the addition of strong acids or strong bases. against pharmaceutical companies making free pricing illegal, it fulfilled ful·fill also ful·fil
tr.v. ful·filled, ful·fill·ing, ful·fills also ful·fils
1. To bring into actuality; effect: fulfilled their promises.
2. the goal of providing quality drugs to the public at reasonable rates.
The introduction of the IPA - which did not recognize product patents but only process patents - provided a major thrust to the industry and its companies, which, through the process of reverse-engineering, began to produce bulk drugs and formulations at lower costs. This led to high fragmentation (1) Storing data in non-contiguous areas on disk. As files are updated, new data are stored in available free space, which may not be contiguous. Fragmented files cause extra head movement, slowing disk accesses. A defragger program is used to rewrite and reorder all the files. in the industry, due to the emergence of a number of small firms.
Thus, there are today about 24,000 companies - big, medium and small - fighting for a USD USD
In currencies, this is the abbreviation for the U.S. Dollar.
The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 5 Billion market. Out of these around 300 are in the organized sector, around 15,000 being in the small scale sector and the remaining being very small without any economies of scale.
India India, officially Republic of India, republic (2005 est pop. 1,080,264,000), 1,261,810 sq mi (3,268,090 sq km), S Asia. The second most populous country in the world, it is also sometimes called Bharat, its ancient name. India's land frontier (c. manufactures over 400 bulk drugs and around 60,000 formulations, which are distributed by 5,000,000 chemists This is a list of famous chemists: (alphabetical order)
: Top - 0–9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
The Indian pharmaceutical industry is passing through a wave of consolidation, with the objective to strengthen their brand equity and distribution in what is essentially a branded-generics market.
In the period 1995-98, the Indian Pharma industry witnessed as many as 20 mergers, acquisitions and takeovers. During the same period, globally the pharmaceutical industry also witnessed mega mergers.
Topics Covered 1. Overview 2. Introduction 3. The Indian Market 4. Characteristics of the Indian Pharmaceutical Industry 5. Key Players in the Indian Pharmaceutical Industry 6. Strategic Groups 7. Critical Success Factors (CSF) of the Industry 8. A Farsighted Strategy in Competition and Cooperation 9. Indian Pharma Exports 10. Policies and Regulations 11. Changing Scenario of Product Patent Regime 12. Laws Pertaining to Manufacture and Sale of Drugs in India 13. Marketing and Distribution in the Pharmaceutical Industry 14. The Changing External Environment 15. Porters Five Forces Model 16. Future Outlook for the Indian Pharmaceutical Industry 17. Emerging Trends 18. India--The Clinical Trial Destination 19. Risks--Weaknesses and Threats--Faced by Indian Industry 20. Intellectual Property and Access to Medicines 21. Evolving Indian Drug Research and Development 22. Case of a Leading Indian Firm--Ranbaxy Laboratories 23. Strategic Options for Pharmaceutical Firms 24. How to Build Sustainable Competitive Advantage
The purpose of this study is to describe the specific segment of the pharmaceutical market sector called the Indian pharmaceutical industry. This sector includes all of the generally accepted pharmaceutical manufacturing activities that are currently used today, including the bulk drug industry, formulations and major therapeutic segments. It examines these clinical supplies as utilized in hospitals, clinics and doctor's offices.
For more information visit http://www.researchandmarkets.com/reports/c29907